COMMUNIQUÉS West-GlobeNewswire

Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), today announced that the Company granted a non-qualified stock option to purchase up to 275,000 shares of the Company’s [...]
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
10/09/2026
NEWTON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic [...]
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™
10/09/2026
● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ● CALGARY, Alberta, Sept. 10, 2026 (GLOBE NEWSWIRE) -- XORTX [...]
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
10/09/2026
Technology transfer to LyFE Manufacturing Center™ completed following FDA review of improved manufacturing process and updated analytical methods Dosing of additional patients with the new process at LyFE continues with [...]
Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
HUNTSVILLE, AL, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug [...]
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
10/09/2026
GAITHERSBURG, Md., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive [...]
COSCIENS ACQUIRES NUALTIS CORP.
10/09/2026
TORONTO, ONTARIO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) is pleased to announce the acquisition of Nualtis Corp. (“ Nualtis ”), a Montreal [...]
Flyte Partners With Christian Cowan for New York Fashion Week, Expanding Its Presence Across Global Luxury Brands
10/09/2026
Strategic Partnership Positions Flyte at the Intersection of Private Aviation, Fashion, and Entertainment Collaboration Introduces Flyte to a High-Value Audience of Celebrities, Executives, Creators and Cultural [...]
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
10/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today [...]
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/09/2026
DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the granting of an inducement award of restricted stock [...]
GENFIT annonce sa participation à la H.C. Wainwright 28th Annual Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, États-Unis), le 10 septembre 2026 – GENFIT (Euronext : GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie [...]
GENFIT to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
Lille (France), Cambridge (Massachusetts, United States), September 10, 2026 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026
10/09/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 août 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026
10/09/2026
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
10/09/2026
Results from the planned interim analysis of the Phase 3 REZILIENT3 trial of zipalertinib plus chemotherapy in first-line EGFR exon 20 insertion mutation NSCLC to be presented in Presidential Symposium 2 on Sunday, [...]
Guidance for the 2026/27 financial year
10/09/2026
ANNOUNCEMENT NO. 312 10 September 2026 ChemoMetec today approved the annual report for 2025/26, including the guidance for 2026/27, which is considered inside information. For the financial year 2026/27, ChemoMetec [...]
Positioning ChemoMetec for future growth
10/09/2026
ANNOUNCEMENT NO. 313 10 September 2026 Annual Report 2025/26 (1 July 2025 - 30 June 2026) Positioning ChemoMetec for future growth Despite changes and uncertainty affecting ChemoMetec's markets, revenue grew by 3% to [...]
LifeLabs Celebrates 11 Family Scholarship Recipients for 2026
10/09/2026
Toronto, Canada, Sept. 10, 2026 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of laboratory diagnostic information and digital health connectivity systems, is proud to announce the outstanding recipients of [...]
Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company
10/09/2026
New production framework designed to support continuous manufacturing, greater operating efficiency and long-term program visibility LITTLETON, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc [...]

Pages